Comparison of Different Molecular Subtypes with 14% Ki-67 Cut-off Threshold in Breast Cancer Patients of Pakistan- An Indication of Poor Prognosis

Mehreen Mushtaq ^1,2, Summaya Sohail Chaudry ¹ , Ahmareen Khalid Sheikh ¹, Nazia Khan ¹, Asma Khattak ¹, Aisha Akbar ³, Ashok Kumar Tanwani ¹, Tanwir Khaliq ⁴, Muhammad Faraz Arshad Malik ⁵, Syeda Kiran Riaz ^1,5,6 *

Cited by CrossRef: 3

1- Okecha T, Yahaya J, Waiswa A, Nyakato V, Mawanda A, Bogere N, Lutada L, Niyonzima N. Ki67 Expression and Its Association With Clinicopathological Factors and Intrinsic Subtypes of Male Breast Cancer in Uganda: A Cross-sectional Study. Breast Cancer�(Auckl). 2025;19 [Crossref]

2- Yaneva G, Dimitrova T, Ivanov D, Ingilizova G, Slavov S. Immunohistochemical Marker Patterns in Female Breast Cancer. Open Access Maced J Med Sci. 2022;10(B):1595 [Crossref]

3- Li Y, Chen T, Du F, Wang H, Ma L. Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtyping. 2023;102(38):e35272 [Crossref]

4- Meretukov D, Grechukhina K, Evdokimov V, Didych D, Kondratieva S, Rakitina O, Gordeev A, Shilo P, Khatkov I, Zhukova L. Deriving Real-World Evidence from Non-English Electronic Medical Records in Hormone Receptor-Positive Breast Cancer Using Large Language Models. Cancers. 2025;17(23):3836 [Crossref]

5- Shanthala S, Amirtham U, Lokesh K, Jacob L, Babu G. Clinicopathological Evaluation of Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center. South Asian J Cancer. 2025;14(01):015 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.